ArticleScientific reports2025
Development and evaluation of Chia seed-based nanofibers and nanoemulsions for Bacillus coagulans Encapsulation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study explores the encapsulation efficiency of composite nanofibers and nanoemulsions derived from chia seed mucilage (Salvia hispanica L.), a natural hydrocolloid with notable bioactive properties. Nanofibers, known for their high surface area and stability, and nanoemulsions, recognized for their enhanced bioavailability, were utilized to encapsulate Bacillus coagulans. Chia mucilage demonstrated a DPPH radical scavenging activity of 67.88% at 350 µg/mL and moderate antimicrobial effects, with inhibition zones of 9 mm and 6 mm against Staphylococcus aureus and Escherichia coli, respectively. Nanofibers prepared with 2-3% mucilage showed uniform morphology (diameters: 12.36-26.24 μm) and significantly higher encapsulation efficiency (93.90[Formula: see text]2.1) (p < 0.05) than nanoemulsions (88.33[Formula: see text]2). FTIR analysis confirmed the successful encapsulation of Bacillus coagulans, with characteristic peaks in the ranges of 1500-1600 cm⁻¹, 2800-3000 cm⁻¹, and 3200-3500 cm⁻¹. These findings suggest that chia seed mucilage-based nanofibers offer a stable and efficient platform for probiotic delivery, with promising applications in functional foods, pharmaceuticals, and cosmetics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.